Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Dis Esophagus

Retrieve available abstracts of 111 articles:
HTML format
Text format



Single Articles


    May 2017
  1. HE Y, Liu J, Zhao Z, Zhao H, et al
    Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  2. CHEN HL, Shen WQ, Liu K
    Radioactive self-expanding stents for palliative management of unresectable esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2017;30:1-16.
    PubMed     Text format     Abstract available


  3. AKIYAMA Y, Iwaya T, Endo F, Shioi Y, et al
    Stability of cervical esophagogastrostomy via hand-sewn anastomosis after esophagectomy for esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


    April 2017
  4. ZHANG Z, Zhang H
    Impact of neoadjuvant chemotherapy and chemoradiotherapy on postoperative cardiopulmonary complications in patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  5. LACERDA CF, Cruvinel-Carloni A, de Oliveira AT, Scapulatempo-Neto C, et al
    Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagus.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


  6. DE B, Rhome R, Doucette J, Buckstein M, et al
    Dose escalation of definitive radiation is not associated with improved survival for cervical esophageal cancer: a National Cancer Data Base (NCDB) analysis.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Text format     Abstract available


  7. VAN RULER MA, Peters FP, Slingerland M, Fiocco M, et al
    Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


  8. RATNASINGHAM K, Stroud L, Knight J, Preston SR, et al
    Analysis of 11 years of clinical negligence claims in esophagogastric cancer in England.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  9. DUAN J, Deng T, Ying G, Zhang H, et al
    Prognostic significance of the T2 substage in patients with esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


    November 2016
  10. FANG HY, Chao YK, Chang HK, Tseng CK, et al
    Survival outcomes of consolidation chemoradiotherapy in esophageal cancer patients who achieve clinical complete response but refuse surgery after neoadjuvant chemoradiotherapy.
    Dis Esophagus. 2016 Nov 23. doi: 10.1111/dote.12515.
    PubMed     Text format     Abstract available


  11. ZHANG F, Wang Y, Wang ZQ, Sun P, et al
    Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12490.
    PubMed     Text format     Abstract available


  12. MIKHAIL S, Wei L, Salem ME, Bekaii-Saab T, et al
    Outcomes of definitive chemoradiation in patients with esophageal cancer.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12506.
    PubMed     Text format     Abstract available


  13. LIN Y, Shen LY, Fu H, Dong B, et al
    P21, COX-2, and E-cadherin are potential prognostic factors for esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12522.
    PubMed     Text format     Abstract available


  14. CHAO YK, Chang HK, Tseng CK, Liu YH, et al
    Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12519.
    PubMed     Text format     Abstract available


  15. LI J, Tang Y, Huang L, Yu Q, et al
    A high number of stromal tumor-infiltrating lymphocytes is a favorable independent prognostic factor in M0 (stages I-III) esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12518.
    PubMed     Text format     Abstract available


  16. BABA Y, Saeki H, Nakashima Y, Oki E, et al
    Review of chemotherapeutic approaches for operable and inoperable esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12521.
    PubMed     Text format     Abstract available


  17. GUINAN EM, Dowds J, Donohoe C, Reynolds JV, et al
    The physiotherapist and the esophageal cancer patient: from prehabilitation to rehabilitation.
    Dis Esophagus. 2016 Nov 9. doi: 10.1111/dote.12514.
    PubMed     Text format     Abstract available


  18. SHUTO K, Kono T, Akutsu Y, Uesato M, et al
    Naso-esophageal extraluminal drainage for postoperative anastomotic leak after thoracic esophagectomy for patients with esophageal cancer.
    Dis Esophagus. 2016 Nov 9. doi: 10.1111/dote.12492.
    PubMed     Text format     Abstract available


  19. TAKEBAYASHI K, Tsubosa Y, Matsuda S, Kawamorita K, et al
    Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer.
    Dis Esophagus. 2016 Nov 9. doi: 10.1111/dote.12502.
    PubMed     Text format     Abstract available


    October 2016
  20. JEENE PM, Versteijne E, van Berge Henegouwen MI, Bergmann JJ, et al
    Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
    Dis Esophagus. 2016 Oct 21. doi: 10.1111/dote.12539.
    PubMed     Text format     Abstract available


  21. TAN JT, Yang Y, Mao NQ, Liu DS, et al
    Effect of neoadjuvant chemoradiotherapy on perioperative immune function of patients with locally advanced esophageal cancer.
    Dis Esophagus. 2016 Oct 21. doi: 10.1111/dote.12486.
    PubMed     Text format     Abstract available


  22. RICE TW, Apperson-Hansen C, DiPaola LM, Semple ME, et al
    Worldwide Esophageal Cancer Collaboration: clinical staging data.
    Dis Esophagus. 2016;29:707-714.
    PubMed     Text format     Abstract available


  23. RICE TW, Lerut TE, Orringer MB, Chen LQ, et al
    Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data.
    Dis Esophagus. 2016;29:715-723.
    PubMed     Text format     Abstract available


  24. RICE TW, Chen LQ, Hofstetter WL, Smithers BM, et al
    Worldwide Esophageal Cancer Collaboration: pathologic staging data.
    Dis Esophagus. 2016;29:724-733.
    PubMed     Text format     Abstract available


  25. ZHANG L, Zhao W, Zheng Z, Wang T, et al
    Hydrogen sulfide synthesis enzymes reduced in lower esophageal sphincter of patients with achalasia.
    Dis Esophagus. 2016;29:801-806.
    PubMed     Text format     Abstract available


  26. LEE HW, Kwon J, Kang MC, Noh MK, et al
    Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.
    Dis Esophagus. 2016;29:848-855.
    PubMed     Text format     Abstract available


  27. CHEN JY, Yang H, Wen J, Luo KJ, et al
    Association between positive murine double minute 2 expression and clinicopathological characteristics of esophageal squamous cell carcinoma: a meta-analysis.
    Dis Esophagus. 2016;29:856-863.
    PubMed     Text format     Abstract available


  28. LEE DS, Ahn YC, Eom DW, Lee SJ, et al
    Primary esophageal mucosa-associated lymphoid tissue lymphoma diagnosed by using stacked forceps biopsy.
    Dis Esophagus. 2016;29:887-890.
    PubMed     Text format     Abstract available


  29. RATUAPLI SK, Thind K, Fleischer DE, Shiff AD, et al
    Esophageal leukoplakia: a rare cause of white patches in esophagus with malignant potential.
    Dis Esophagus. 2016;29:885.
    PubMed     Text format    


    September 2016
  30. KANEMURA T, Makino T, Miyazaki Y, Takahashi T, et al
    Distribution patterns of metastases in recurrent laryngeal nerve lymph nodes in patients with squamous cell esophageal cancer.
    Dis Esophagus. 2016 Sep 15. doi: 10.1111/dote.12527.
    PubMed     Text format     Abstract available


  31. USHIKU H, Yamashita K, Katoh H, Ema A, et al
    Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Sep 15. doi: 10.1111/dote.12496.
    PubMed     Text format     Abstract available


  32. RODRIGUES-PINTO E, Pereira P, Coelho R, Andrade P, et al
    Outcome and risk factors assessment for adverse events in advanced esophageal cancer patients after self-expanding metal stents placement.
    Dis Esophagus. 2016 Sep 15. doi: 10.1111/dote.12467.
    PubMed     Text format     Abstract available


    June 2016
  33. TAN D, Wu Y, Hu L, He P, et al
    Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
    Dis Esophagus. 2016 Jun 1. doi: 10.1111/dote.12481.
    PubMed     Text format     Abstract available


    May 2016
  34. PENG J, Cai J, Niu ZX, Chen LQ, et al
    Early enteral nutrition compared with parenteral nutrition for esophageal cancer patients after esophagectomy: a meta-analysis.
    Dis Esophagus. 2016;29:333-41.
    PubMed     Text format     Abstract available


  35. PARK SY, Kim DJ, Yu WS, Jung HS, et al
    Robot-assisted thoracoscopic esophagectomy with extensive mediastinal lymphadenectomy: experience with 114 consecutive patients with intrathoracic esophageal cancer.
    Dis Esophagus. 2016;29:326-32.
    PubMed     Text format     Abstract available


  36. HARADA K, Mine S, Yamada K, Shigaki H, et al
    Long-term outcome of esophagectomy for primary malignant melanoma of the esophagus: a single-institute retrospective analysis.
    Dis Esophagus. 2016;29:314-9.
    PubMed     Text format     Abstract available


  37. DOLAN JP, Kaur T, Diggs BS, Luna RA, et al
    Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy.
    Dis Esophagus. 2016;29:320-5.
    PubMed     Text format     Abstract available


  38. SUNPAWERAVONG S, Sunpaweravong P, Sathitruangsak C, Mai S, et al
    Three-dimensional telomere architecture of esophageal squamous cell carcinoma: comparison of tumor and normal epithelial cells.
    Dis Esophagus. 2016;29:307-13.
    PubMed     Text format     Abstract available


    April 2016
  39. ZU Y, Ping W, Deng T, Zhang N, et al
    Lipopolysaccharide-induced toll-like receptor 4 signaling in esophageal squamous cell carcinoma promotes tumor proliferation and regulates inflammatory cytokines expression.
    Dis Esophagus. 2016 Apr 7. doi: 10.1111/dote.12466.
    PubMed     Text format     Abstract available


  40. QU Y, Zhang S, Cui L, Wang K, et al
    Two novel polymorphisms in PLCE1 are associated with the susceptibility to esophageal squamous cell carcinoma in Chinese population.
    Dis Esophagus. 2016 Apr 7. doi: 10.1111/dote.12463.
    PubMed     Text format     Abstract available


  41. KAMACHI K, Ozawa S, Hayashi T, Kazuno A, et al
    Impact of body mass index on postoperative complications and long-term survival in patients with esophageal squamous cell cancer.
    Dis Esophagus. 2016;29:229-35.
    PubMed     Text format     Abstract available


  42. SIMON M, Mal F, Perniceni T, Ferraz JM, et al
    Accuracy of staging laparoscopy in detecting peritoneal dissemination in patients with gastroesophageal adenocarcinoma.
    Dis Esophagus. 2016;29:236-40.
    PubMed     Text format     Abstract available


  43. RHEE K, Kim JH, Jung DH, Han JW, et al
    Self-expandable metal stents for malignant esophageal obstruction: a comparative study between extrinsic and intrinsic compression.
    Dis Esophagus. 2016;29:224-8.
    PubMed     Text format     Abstract available


  44. ZHAN L, Qin Q, Lu J, Liu J, et al
    Novel poly (ADP-ribose) polymerase inhibitor, AZD2281, enhances radiosensitivity of both normoxic and hypoxic esophageal squamous cancer cells.
    Dis Esophagus. 2016;29:215-23.
    PubMed     Text format     Abstract available


  45. TANG X, Fan Z, Wang Y, Ji G, et al
    Expression of klotho and beta-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
    Dis Esophagus. 2016;29:207-14.
    PubMed     Text format     Abstract available


    March 2016
  46. LIU F, Tian T, Xia LL, Ding Y, et al
    Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Dis Esophagus. 2016 Mar 22. doi: 10.1111/dote.12489.
    PubMed     Text format     Abstract available


  47. MIYAWAKI Y, Nakajima Y, Kawada K, Okada T, et al
    Efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy for superficial esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Mar 22. doi: 10.1111/dote.12485.
    PubMed     Text format     Abstract available


  48. BABA Y, Baba H, Yamamoto S, Shimada H, et al
    Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan.
    Dis Esophagus. 2016 Mar 22. doi: 10.1111/dote.12482.
    PubMed     Text format     Abstract available


  49. HAGEN PV, Heijl MV, Henegouwen MI, Boellaard R, et al
    Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study.
    Dis Esophagus. 2016 Mar 22. doi: 10.1111/dote.12479.
    PubMed     Text format     Abstract available


    February 2016
  50. OPSTELTEN JL, de Wijkerslooth LR, Leenders M, Bac DJ, et al
    Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions.
    Dis Esophagus. 2016 Feb 26. doi: 10.1111/dote.12478.
    PubMed     Text format     Abstract available


  51. PARRY K, Ruurda JP, van der Sluis PC, van Hillegersberg R, et al
    Current status of laparoscopic transhiatal esophagectomy for esophageal cancer patients: a systematic review of the literature.
    Dis Esophagus. 2016 Feb 26. doi: 10.1111/dote.12477.
    PubMed     Text format     Abstract available


  52. MATSUDA S, Tsubosa Y, Sato H, Takebayashi K, et al
    Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Feb 26. doi: 10.1111/dote.12473.
    PubMed     Text format     Abstract available


  53. DU D, Song T, Liang X, Fang M, et al
    Concurrent chemoradiotherapy with elective lymph node irradiation for esophageal cancer: a systemic review and pooled analysis of the literature.
    Dis Esophagus. 2016 Feb 26. doi: 10.1111/dote.12471.
    PubMed     Text format     Abstract available


  54. TAN HZ, Lin WJ, Huang JQ, Dai M, et al
    Updated incidence rates and risk factors of esophageal cancer in Nan'ao Island, a coastal high-risk area in southern China.
    Dis Esophagus. 2016 Feb 26. doi: 10.1111/dote.12468.
    PubMed     Text format     Abstract available


  55. XU Y, Qiu M, Chen Y, Wang J, et al
    Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Feb 2. doi: 10.1111/dote.12436.
    PubMed     Text format     Abstract available


  56. YANG H, Wang J, Huang Q, Zheng Y, et al
    Intraoperative ultrasonography for the identification of thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer.
    Dis Esophagus. 2016;29:152-8.
    PubMed     Text format     Abstract available


  57. YIP C, Cook GJ, Landau DB, Davies A, et al
    Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer.
    Dis Esophagus. 2016;29:116-30.
    PubMed     Text format    


  58. OTOWA Y, Nakamura T, Takiguchi G, Tomono A, et al
    Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
    Dis Esophagus. 2016;29:146-51.
    PubMed     Text format     Abstract available


  59. GUO W, Ma L, Zhang Y, Ma X, et al
    Totally minimally invasive Ivor-Lewis esophagectomy with single-utility incision video-assisted thoracoscopic surgery for treatment of mid-lower esophageal cancer.
    Dis Esophagus. 2016;29:139-45.
    PubMed     Text format     Abstract available


  60. FUJIWARA H, Shiozaki A, Konishi H, Komatsu S, et al
    Hand-assisted laparoscopic transhiatal esophagectomy with a systematic procedure for en bloc infracarinal lymph node dissection.
    Dis Esophagus. 2016;29:131-8.
    PubMed     Text format     Abstract available


    January 2016
  61. LU Z, Wang J, Zheng Y, Yang S, et al
    Wild-type phosphatase and tensin homolog deleted on chromosome 10 improved the sensitivity of cells to rapamycin through regulating phosphorylation of Akt in esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Jan 3. doi: 10.1111/dote.12448.
    PubMed     Text format     Abstract available


  62. EIZAGUIRRE E, Larburu S, Asensio JI, Rodriguez A, et al
    Treatment of anastomotic leaks with metallic stent after esophagectomies.
    Dis Esophagus. 2016;29:86-92.
    PubMed     Text format     Abstract available


  63. WORMALD JC, Bennett J, van Leuven M, Lewis MP, et al
    Does the site of anastomosis for esophagectomy affect long-term quality of life?
    Dis Esophagus. 2016;29:93-8.
    PubMed     Text format     Abstract available


  64. SAHIN M, Ogut MF, Vardar R, Kirazli T, et al
    Novel esophageal speech therapy method in total laryngectomized patients: biofeedback by intraesophageal impedance.
    Dis Esophagus. 2016;29:41-7.
    PubMed     Text format     Abstract available


  65. XIE X, Luo KJ, Hu Y, Wang JY, et al
    Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
    Dis Esophagus. 2016;29:79-85.
    PubMed     Text format     Abstract available


  66. JIANG H, Cui Y, Ma K, Gong M, et al
    Experimental reconstruction of cervical esophageal defect with artificial esophagus made of polyurethane in a dog model.
    Dis Esophagus. 2016;29:62-9.
    PubMed     Text format     Abstract available


  67. WANG ZM, Kang YH, Yang X, Wang JF, et al
    Andrographolide radiosensitizes human esophageal cancer cell line ECA109 to radiation in vitro.
    Dis Esophagus. 2016;29:54-61.
    PubMed     Text format     Abstract available


    December 2015
  68. HORGAN AM, Darling G, Wong R, Guindi M, et al
    Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.
    Dis Esophagus. 2015 Dec 10. doi: 10.1111/dote.12444.
    PubMed     Text format     Abstract available


  69. DENG JY, Wang C, Shi XH, Jiang GL, et al
    Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clini
    Dis Esophagus. 2015 Dec 10. doi: 10.1111/dote.12435.
    PubMed     Text format     Abstract available


    November 2015
  70. DING YQ, Zhu HC, Chen XC, Sun XC, et al
    Sunitinib modulates the radiosensitivity of esophageal squamous cell carcinoma cells in vitro.
    Dis Esophagus. 2015 Nov 6. doi: 10.1111/dote.12440.
    PubMed     Text format     Abstract available


  71. OKUMURA H, Mori N, Tanaka T, Morita M, et al
    Clinical features and treatment of patients with esophageal cancer and a history of gastrectomy: a multicenter, questionnaire survey in Kyushu, Japan.
    Dis Esophagus. 2015 Nov 6. doi: 10.1111/dote.12439.
    PubMed     Text format     Abstract available


  72. HELLSTADIUS Y, Lagergren J, Zylstra J, Gossage J, et al
    Prevalence and predictors of anxiety and depression among esophageal cancer patients prior to surgery.
    Dis Esophagus. 2015 Nov 6. doi: 10.1111/dote.12437.
    PubMed     Text format     Abstract available


  73. LIN G, Han SY, Xu YP, Mao WM, et al
    Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.
    Dis Esophagus. 2015 Nov 6. doi: 10.1111/dote.12432.
    PubMed     Text format     Abstract available


  74. XU X, Chen G, Wu L, Liu L, et al
    Association of genetic polymorphisms in PTEN and additional gene-gene interaction with risk of esophageal squamous cell carcinoma in Chinese Han population.
    Dis Esophagus. 2015 Nov 6. doi: 10.1111/dote.12428.
    PubMed     Text format     Abstract available


    October 2015
  75. HIHARA J, Hamai Y, Emi M, Murakami Y, et al
    Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study.
    Dis Esophagus. 2015 Oct 15. doi: 10.1111/dote.12433.
    PubMed     Text format     Abstract available


  76. KIMURA J, Kunisaki C, Makino H, Oshima T, et al
    Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer.
    Dis Esophagus. 2015 Oct 15. doi: 10.1111/dote.12420.
    PubMed     Text format     Abstract available


  77. STRAATMAN J, Joosten PJ, Terwee CB, Cuesta MA, et al
    Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer.
    Dis Esophagus. 2015 Oct 15. doi: 10.1111/dote.12405.
    PubMed     Text format     Abstract available


  78. GONG EJ, Kim DH, Ahn JY, Choi KS, et al
    Routine endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma: a prospective study.
    Dis Esophagus. 2015 Oct 15. doi: 10.1111/dote.12404.
    PubMed     Text format     Abstract available


  79. GRAHAM L, Wikman A
    Toward improved survivorship: supportive care needs of esophageal cancer patients, a literature review.
    Dis Esophagus. 2015 Oct 12. doi: 10.1111/dote.12424.
    PubMed     Text format     Abstract available


  80. DIXON JL, Copeland LA, Zeber JE, MacCarthy AA, et al
    Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population.
    Dis Esophagus. 2015 Oct 12. doi: 10.1111/dote.12402.
    PubMed     Text format     Abstract available


    September 2015
  81. NOORDMAN BJ, Wijnhoven BP, van Lanschot JJ
    Optimal surgical approach for esophageal cancer in the era of minimally invasive esophagectomy and neoadjuvant therapy.
    Dis Esophagus. 2015 Sep 18. doi: 10.1111/dote.12407.
    PubMed     Text format     Abstract available


  82. QIAO YF, Chen CG, Yue J, Ma Z, et al
    Clinical significance of preoperative and postoperative cytokeratin 19 messenger RNA level in peripheral blood of esophageal cancer patients.
    Dis Esophagus. 2015 Sep 18. doi: 10.1111/dote.12403.
    PubMed     Text format     Abstract available


  83. FANG TC, Oh YS, Szabo A, Khan A, et al
    Utility of dysphagia grade in predicting endoscopic ultrasound T-stage of non-metastatic esophageal cancer.
    Dis Esophagus. 2015 Sep 18. doi: 10.1111/dote.12394.
    PubMed     Text format     Abstract available


    August 2015
  84. HAN L, Jia Y, Song Q, Wang N, et al
    Prognostic significance of preoperative absolute peripheral monocyte count in esophageal squamous cell carcinoma.
    Dis Esophagus. 2015 Aug 28. doi: 10.1111/dote.12401.
    PubMed     Text format     Abstract available


  85. KUMAGAI K, Mariosa D, Tsai JA, Nilsson M, et al
    Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
    Dis Esophagus. 2015 Aug 28. doi: 10.1111/dote.12399.
    PubMed     Text format     Abstract available


    July 2015
  86. CHIU CH, Chen WH, Wen YW, Yeh CJ, et al
    Association between the thoroughness of the histopathological examination and survival in patients with esophageal squamous cell carcinoma who achieve pathological complete response after chemoradiotherapy.
    Dis Esophagus. 2015 Jul 14. doi: 10.1111/dote.12388.
    PubMed     Text format     Abstract available


    June 2015
  87. HARADA K, Ida S, Baba Y, Ishimoto T, et al
    Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma.
    Dis Esophagus. 2015 Jun 30. doi: 10.1111/dote.12381.
    PubMed     Text format     Abstract available


  88. WEN YS, Huang C, Zhang X, Qin R, et al
    Impact of metabolic syndrome on the survival of Chinese patients with resectable esophageal squamous cell carcinoma.
    Dis Esophagus. 2015 Jun 30. doi: 10.1111/dote.12376.
    PubMed     Text format     Abstract available


    May 2015
  89. FAGUNDES RB, de Carli D, Xaubet RV, Cantarelli JC Jr, et al
    Unchanging pattern of prevalence of esophageal cancer, overall and by histological subtype, in the endoscopy service of the main referral hospital in the central region of Rio Grande do Sul State, in Southern Brazil.
    Dis Esophagus. 2015 May 13. doi: 10.1111/dote.12350.
    PubMed     Text format     Abstract available


  90. REALDON S, Dassie E, Fassan M, Dall'Olmo L, et al
    In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma.
    Dis Esophagus. 2015;28:394-403.
    PubMed     Text format     Abstract available


  91. ANTONOWICZ SS, Lorenzi B, Parker M, Tang CB, et al
    Annual computed tomography scans do not improve outcomes following esophagectomy for cancer: a 10-year UK experience.
    Dis Esophagus. 2015;28:365-70.
    PubMed     Text format     Abstract available


  92. VAN HAGEN P, Biermann K, Boers JE, Stoss O, et al
    Human epidermal growth factor receptor 2 overexpression and amplification in endoscopic biopsies and resection specimens in esophageal and junctional adenocarcinoma.
    Dis Esophagus. 2015;28:380-5.
    PubMed     Text format     Abstract available


  93. BOERWINKEL DF, Holz JA, Hawkins DM, Curvers WL, et al
    Fluorescence spectroscopy incorporated in an Optical Biopsy System for the detection of early neoplasia in Barrett's esophagus.
    Dis Esophagus. 2015;28:345-51.
    PubMed     Text format     Abstract available


  94. GUO J, Liu Z, Sun S, Liu X, et al
    Ligation-assisted endoscopic enucleation for treatment of esophageal subepithelial lesions originating from the muscularis propria: a preliminary study.
    Dis Esophagus. 2015;28:312-7.
    PubMed     Text format     Abstract available


  95. LEE YY, McColl KE
    Disruption of the gastroesophageal junction by central obesity and waist belt: role of raised intra-abdominal pressure.
    Dis Esophagus. 2015;28:318-25.
    PubMed     Text format     Abstract available


    April 2015
  96. PERRY C, Soomro I, Kaye P, Hardy E, et al
    Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication.
    Dis Esophagus. 2015;28:262-8.
    PubMed     Text format     Abstract available


  97. AHMAD J, Arthur K, Maxwell P, Kennedy A, et al
    A cross sectional study of p504s, CD133, and Twist expression in the esophageal metaplasia dysplasia adenocarcinoma sequence.
    Dis Esophagus. 2015;28:276-82.
    PubMed     Text format     Abstract available


  98. KHALAF N, Ramsey D, Kramer JR, El-Serag HB, et al
    Personal and family history of cancer and the risk of Barrett's esophagus in men.
    Dis Esophagus. 2015;28:283-90.
    PubMed     Text format     Abstract available


  99. KUMAGAI Y, Kawada K, Higashi M, Ishiguro T, et al
    Endocytoscopic observation of various esophageal lesions at x600: can nuclear abnormality be recognized?
    Dis Esophagus. 2015;28:269-75.
    PubMed     Text format     Abstract available


    February 2015
  100. UI T, Fujii H, Hosoya Y, Nagase M, et al
    Comparison of preoperative chemotherapy using docetaxel, cisplatin and fluorouracil with cisplatin and fluorouracil in patients with advanced carcinoma of the thoracic esophagus.
    Dis Esophagus. 2015;28:180-7.
    PubMed     Text format     Abstract available


  101. PICARDO SL, O'Brien MP, Feighery R, O'Toole D, et al
    A Barrett's esophagus registry of over 1000 patients from a specialist center highlights greater risk of progression than population-based registries and high risk of low grade dysplasia.
    Dis Esophagus. 2015;28:121-6.
    PubMed     Text format     Abstract available


  102. OYA H, Kanda M, Takami H, Hibino S, et al
    Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus.
    Dis Esophagus. 2015;28:188-95.
    PubMed     Text format     Abstract available


    January 2015
  103. HERRERO LA, van Vilsteren FG, Visser M, Meijer SL, et al
    Simultaneous use of endoscopic resection and radiofrequency ablation is not safe in an esophageal porcine model.
    Dis Esophagus. 2015;28:25-31.
    PubMed     Text format     Abstract available


  104. DUNN LJ, Shenfine J, Griffin SM
    Columnar metaplasia in the esophageal remnant after esophagectomy: a systematic review.
    Dis Esophagus. 2015;28:32-41.
    PubMed     Text format     Abstract available


  105. BOONSTRA JJ, Tilanus HW, Dinjens WN
    Translational research on esophageal adenocarcinoma: from cell line to clinic.
    Dis Esophagus. 2015;28:90-6.
    PubMed     Text format     Abstract available


    September 2014
  106. NIE S, Chen T, Yang X, Huai P, et al
    Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis.
    Dis Esophagus. 2014;27:645-53.
    PubMed     Text format     Abstract available


  107. GKIKA E, Gauler T, Eberhardt W, Stahl M, et al
    Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
    Dis Esophagus. 2014;27:678-84.
    PubMed     Text format     Abstract available


  108. TZAO C, Jin JS, Chen BH, Chung HY, et al
    Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
    Dis Esophagus. 2014;27:693-702.
    PubMed     Text format     Abstract available


  109. TOFTELAND N, Singh M, Gaddam S, Wani SB, et al
    Evaluation of the updated confocal laser endomicroscopy criteria for Barrett's esophagus among gastrointestinal pathologists.
    Dis Esophagus. 2014;27:623-9.
    PubMed     Text format     Abstract available


  110. SATO H, Inoue H, Ikeda H, Grace R Santi E, et al
    Clinical experience of esophageal perforation occurring with endoscopic submucosal dissection.
    Dis Esophagus. 2014;27:617-22.
    PubMed     Text format     Abstract available


    August 2014
  111. ZHANG BH, Zhang HT, Wang YG
    Esophageal leiomyosarcoma: clinical analysis and surgical treatment of 12 cases.
    Dis Esophagus. 2014;27:547-51.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: